Robertp Charrow News Today

World Leaders In Academia, Business, Government, Healthcare, Philanthropy & Science Commit Their Expertise To Advancing The Development & Expansio...

New York, NY (PRWEB) March 24, 2022 -- Fourteen shareholders from global law firm Greenberg Traurig, LLP have been selected as members of Law360’s 2022

Robert Charrow focuses on research, biotechnology, health care issues and represents health care providers, scientists, pharmaceutical companies

Robert Charrow focuses on research, biotechnology, health care issues and represents health care providers, scientists, pharmaceutical companies

To embed, copy and paste the code into your website or blog: On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ actions to limit access to 340B Program pricing for covered entities that dispense medications through contract pharmacies have resulted in overcharges and are in direct violation of the 340B statute. 1 The letters order the manufacturers...

Advertisement 340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute Wednesday, May 26, 2021 On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six pharmaceutical manufacturers stating that the manufacturers’ actions to limit access to 340B Program pricing for covered entities that dispense medications through contract pha...

Share WASHINGTON, D.C. – May 25, 2021 – The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firm’s Health Care & FDA Practice. “Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firms cultural and quality fabric his first time with us. Having ...

Share this article Share this article WASHINGTON, May 25, 2021 /PRNewswire/ -- The former U.S. Department of Health and Human Services (HHS) General Counsel, Robert P. Charrow, has returned to the Washington, D.C. office of global law firm Greenberg Traurig, LLP. Charrow joins as senior chairman of the firms Health Care & FDA Practice. "Bob is a proven leader and key figure in the health care industry. Indeed, he was previously a valued leader and part of the firms cultural and quality fabric ...

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.

In Featured, News by Ged Kenslea December 30, 2020 On Wednesday, the HHS Office of the General Counsel released an advisory opinion concluding that drug manufacturers are required to deliver discounts under the 340B Drug Pricing Program on covered outpatient drugs when contract pharmacies are acting as agents of 340B covered entities   they planned to refuse to provide certain drugs at the legally required ‘340B price’ as required by section 340B of the U.S. Public Health Services Act WA...